emergency use authorization (EUA)

Information Sources addressing Topic

21 U.S. Code § 360bbb-3 - Authorization for medical products for use in emergencies
COVID-19 Contracts
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1
Emergency Use Authorization for Vaccines to Prevent COVID-19 - Guidance for Industry
Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) — Emergency Use Authorization (EUA) of the Janssen COVID-19 Vaccine to Prevent Coronavirus Disease 2019 (COVID-19)
Fact Sheet for Recipients and Caregivers - Emergency Use Authorization (EUA) of the Pfizer-Biontech COVID-19 Vaccine to Prevent Coronavirus
FDA Briefing Document - Moderna COVID-19 Vaccine
FDA Briefing Document - Pfizer-BioNTech COVID-19 Vaccine
FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine
mRNA Vaccine Toxicity
Physicians Declaration II
Summary Basis for Regulatory Action
The Book on Masks
The Science Behind Vaccine Research and Testing

Topic ID

544